presentatie - vzw farmaka asbl
presentatie - vzw farmaka asbl
presentatie - vzw farmaka asbl
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Referenties<br />
Anonymous: Startbehandeling van hypertensie: stand van zaken. Folia Farmacotherapeutica april 2004.<br />
Anonymous: Twee studies over startbehandeling van hypertensie. Folia Farmacotherapeutica april 2003.<br />
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in highrisk<br />
hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker<br />
vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA<br />
2002;288:2981-97.<br />
Psaty BM, Lumley T, Furberg CD et al. Health outcomes associated with various antihypertensive therapies<br />
used as first-line agents. A network meta-analysis. JAMA 2003;289:2534-44.<br />
Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a quantitative overview<br />
updated until 1 March 2003. J Hypertension 2003;21:1055-76.<br />
Turnbull F. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering<br />
regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.<br />
Lancet 2003;362:1527-35.<br />
Wing LMH, Reid CMR, Ryan P et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors<br />
and diuretics for hypertension in the elderly. Second Australian Blood Pressure Study Group. NEJM<br />
2003;348:583-92.<br />
Projekt<br />
Farmaka<br />
Vergelijking tussen de verschillende klassen antihypertensiva onderling<br />
Oktober 2004<br />
˜ Fiche 2 ˜